These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 345826)

  • 1. Inhibition of platelet monoamine oxidase in depressed subjects treated with phenelzine.
    Davidson J; McLeod MN; White HL
    Am J Psychiatry; 1978 Apr; 135(4):470-2. PubMed ID: 345826
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acetylation phenotype, platelet monoamine oxidase inhibition, and the effectiveness of phenelzine in depression.
    Davidson J; McLeod MN; Blum MR
    Am J Psychiatry; 1978 Apr; 135(4):467-9. PubMed ID: 345825
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MAO inhibition and clinical response in depressed patients treated with phenelzine.
    Bresnahan DB; Pandey GN; Janicak PG; Sharma R; Boshes RA; Chang SS; Gierl BL; Davis JM
    J Clin Psychiatry; 1990 Feb; 51(2):47-50. PubMed ID: 2298705
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical pharmacology of phenelzine.
    Robinson DS; Nies A; Ravaris CL; Ives JO; Bartlett D
    Arch Gen Psychiatry; 1978 May; 35(5):629-35. PubMed ID: 365127
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prediction of response to nortriptyline and phenelzine by platelet MAO activity.
    Georgotas A; McCue RE; Friedman E; Cooper T
    Am J Psychiatry; 1987 Mar; 144(3):338-40. PubMed ID: 3826434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between response to phenelzine and MAO inhibition in a clinical trial of phenelzine, amitriptyline and placebo.
    Raft D; Davidson J; Wasik J; Mattox A
    Neuropsychobiology; 1981; 7(3):122-6. PubMed ID: 7231652
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular effects of phenelzine and amitriptyline in depressed outpatients.
    Robinson DS; Nies A; Corcella J; Cooper TB; Spencer C; Keefover R
    J Clin Psychiatry; 1982 May; 43(5 Pt 2):8-15. PubMed ID: 7042699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platelet MAO inhibition, urinary MHPG, and leukocyte beta-adrenergic receptors in depressed patients treated with phenelzine.
    Sharma RP; Janicak PG; Javaid JI; Pandey GN; Gierl B; Davis JM
    Am J Psychiatry; 1990 Oct; 147(10):1318-21. PubMed ID: 2169208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resistant geriatric depressions and therapeutic response to monoamine oxidase inhibitors.
    Georgotas A; Friedman E; McCarthy M; Mann J; Krakowski M; Siegel R; Ferris S
    Biol Psychiatry; 1983 Feb; 18(2):195-205. PubMed ID: 6830930
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors affecting the delay of antidepressant effect in responders to nortriptyline and phenelzine.
    Georgotas A; McCue RE; Cooper TB; Nagachandran N; Friedhoff A
    Psychiatry Res; 1989 Apr; 28(1):1-9. PubMed ID: 2662234
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acetylator status and inhibition of platelet monoamine oxidase following treatment with phenelzine.
    Yates CM; Loudon JB
    Psychol Med; 1979 Nov; 9(4):777-9. PubMed ID: 515276
    [No Abstract]   [Full Text] [Related]  

  • 12. Platelet monoamine oxidase inhibition as a potential indicator of favorable response to MAOI's in geriatric depressions.
    Georgotas A; Mann J; Friedman E
    Biol Psychiatry; 1981 Oct; 16(10):997-1001. PubMed ID: 7306621
    [No Abstract]   [Full Text] [Related]  

  • 13. Platelet and plasma amine oxidase inhibition and urinary amine excretion changes during phenelzine treatment.
    Murphy DL; Brand E; Goldman T; Baker M; Wright C; van Kammen D; Gordon E
    J Nerv Ment Dis; 1977 Feb; 164(2):129-34. PubMed ID: 836485
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single case study. Complementary effects of phenelzine and psychotherapy in long term treatment of depression.
    Davidson J; Raft D; Freeman C
    J Nerv Ment Dis; 1979 Oct; 167(10):632-4. PubMed ID: 114605
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of phenelzine and imipramine in depressed inpatients.
    Davidson JR; McLeod MN; Turnbull CD; Miller RD
    J Clin Psychiatry; 1981 Oct; 42(10):395-7. PubMed ID: 7026542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pretreatment dexamethasone suppression test as a predictor of response to phenelzine.
    Janicak PG; Pandey GN; Sharma R; Boshes R; Bresnahan D; Davis JM
    J Clin Psychiatry; 1987 Dec; 48(12):480-2. PubMed ID: 3693333
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma levels of catecholamines and dihydroxyphenylglycol during antidepressant drug treatment.
    Robinson DS; Johnson GA; Nies A; Corcella J; Cooper TB; Albright D; Howard D
    J Clin Psychopharmacol; 1983 Oct; 3(5):282-7. PubMed ID: 6355207
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phenelzine v imipramine in atypical depression. A preliminary report.
    Liebowitz MR; Quitkin FM; Stewart JW; McGrath PJ; Harrison W; Rabkin J; Tricamo E; Markowitz JS; Klein DF
    Arch Gen Psychiatry; 1984 Jul; 41(7):669-77. PubMed ID: 6375621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monoamine oxidase inhibitors phenelzine and brofaromine increase plasma serotonin and decrease 5-hydroxyindoleacetic acid in patients with major depression: relationship to clinical improvement.
    Celada P; Pérez J; Alvarez E; Artigas F
    J Clin Psychopharmacol; 1992 Oct; 12(5):309-15. PubMed ID: 1282522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A multiple-dose, controlled study of phenelzine in depression-anxiety states.
    Ravaris CL; Nies A; Robinson DS; Ives JO; Lamborn KR; Korson L
    Arch Gen Psychiatry; 1976 Mar; 33(3):347-50. PubMed ID: 769725
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.